Cargando…
Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study
BACKGROUND: Palmitoylethanolamide (PEA) is emerging as a new therapeutic approach in pain and inflammatory conditions, and it has been evaluated in studies on various painful diseases. The aim of this open-label study was to evaluate the efficacy of ultramicronized PEA (umPEA) in the prophylactic tr...
Autores principales: | Papetti, Laura, Sforza, Giorgia, Tullo, Giulia, Alaimo di Loro, Pierfrancesco, Moavero, Romina, Ursitti, Fabiana, Ferilli, Michela Ada Noris, Tarantino, Samuela, Vigevano, Federico, Valeriani, Massimiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196162/ https://www.ncbi.nlm.nih.gov/pubmed/32377286 http://dx.doi.org/10.1155/2020/3938640 |
Ejemplares similares
-
Prophylactic Treatment of Pediatric Migraine: Is There Anything New in the Last Decade?
por: Papetti, Laura, et al.
Publicado: (2019) -
Sleep Disorders in Pediatric Migraine: A Questionnaire-Based Study
por: Voci, Alessandra, et al.
Publicado: (2021) -
Anxiety, Depression, and Body Weight in Children and Adolescents With Migraine
por: Tarantino, Samuela, et al.
Publicado: (2020) -
Truths and Myths in Pediatric Migraine and Nutrition
por: Papetti, Laura, et al.
Publicado: (2021) -
Features and Management of New Daily Persistent Headache in Developmental-Age Patients
por: Papetti, Laura, et al.
Publicado: (2021)